or
forgot password

Carotenoid-Rich Diet Trial to Reverse CIN II


Phase 2
18 Years
55 Years
Open (Enrolling)
Female
Cervical Cancer

Thank you

Trial Information

Carotenoid-Rich Diet Trial to Reverse CIN II


OBJECTIVES: I. Determine whether a carotenoid rich diet will cause a significant increase in
the regression of disease in patients with grade I or II cervical intraepithelial dysplasia.
II. Determine whether the regression of disease in this patient population is reflected in
the modulation of intermediate biological markers (viral genome copy number of human
papilloma virus (HPV) and HPV E6/E7 expression).

OUTLINE: This is a randomized, controlled study. Patients are randomized to one of two
treatment arms. Arm I: Patients receive dietary counseling and eat 5-10 servings of
carotenoid rich fruit and vegetables each day for a year. Arm II: Patients receive no
counseling and maintain their normal diet. Carotenoid levels, HPV status, progression of
cervical dysplasia, and diet (by food frequency checklist and food diary) are monitored in
both groups.

PROJECTED ACCRUAL: A total of 240 patients will be accrued for this study within 5 years.

Inclusion Criteria


DISEASE CHARACTERISTICS: Histologically proven cervical intraepithelial dysplasia, grade
CIN II, or CIN I by repeat cytology No invasive carcinoma by Pap smear No positive
endocervical curettage

PATIENT CHARACTERISTICS: Age: 18 to 55 (premenopausal) Performance status: Not specified
Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal:
Not specified Other: No concurrent beta carotene supplements Not pregnant or nursing No
prior malignancy

PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified
Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: At least 6 months
since prior cauterization, cryosurgery, laser, or conization of the cervix

Type of Study:

Interventional

Study Design:

Primary Purpose: Prevention

Principal Investigator

Cheryl L. Rock, PhD, RD

Investigator Role:

Study Chair

Investigator Affiliation:

University of California, San Diego

Authority:

United States: Federal Government

Study ID:

CDR0000065806

NCT ID:

NCT00003094

Start Date:

October 1997

Completion Date:

Related Keywords:

  • Cervical Cancer
  • cervical cancer
  • Uterine Cervical Neoplasms

Name

Location

University of California San Diego Cancer Center La Jolla, California  92093-0658